Background Very short (≤ 3 months) duration of dual antiplatelet therapy (VSDAPT) has
recently been proposed after percutaneous coronary intervention (PCI) with drug-eluting …

Importance The optimal duration of dual antiplatelet therapy (DAPT) for older adults after
percutaneous coronary intervention (PCI) is uncertain because they are simultaneously at …

Background Optimal duration of dual antiplatelet therapy (DAPT) in patients undergoing
complex percutaneous coronary intervention (PCI) remains under investigation. Our aim is …

Abstract Purpose Direct oral anticoagulants (DOACs) have been approved, for over a
decade, by both European and American medicine agencies, for treatment and prevention …

Based on the latest knowledge and technological advancements, it is still debatable whether
a modern revascularisation approach in the setting of acute myocardial infarction (AMI) …

The optimal duration of DAPT after complex PCI remains under investigation. The purpose
of this systematic review and meta-analysis was to explore the safety and efficacy of a one …

Aims: High platelet-derived thrombogenicity during the acute phase of ST-segment elevation
myocardial infarction (STEMI) is associated with poor outcomes; however, the associated …

Background Patients with type 2 diabetes mellitus (DM) comprise more than a quarter of all
patients undergoing percutaneous coronary intervention and are at higher risk of adverse …

Abstract Patients with Acute Coronary Syndrome (ACS) require drug-eluting stent
implantation after percutaneous coronary intervention (PCI), associated with the …

(PCI) with drug-eluting stents, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12
platelet receptor inhibitor is administered to reduce atherothrombotic events involving both …